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kinase was used as thrombolytic agent in all cases with loading dose of
150000 to 250000 units over 30 minutes followed by 100000 units per
hour over next 24 hours or till valve opens whichever is earlier.
Heparin was given prior to thrombolytic therapy and not continued
during thrombolytic therapy. Concomitant oral anticoagulation ther-
apy dose was optimized .Repeat echocardiographic examination was
performed at 6, 12 and 24 hours after initiation of therapy. Clinically,
reappearance of audible metallic click was monitored. Any bleeding
complications both minor and major and neurological worsening was
noted. Safety of thrombolysis is assessed by complications incurred,
directly related or as a consequence of thrombolytic therapy. Efﬁcacy
is assessed by clinical reappearance of metallic click, resumption of
leaﬂet movement in echocardiography and fall in the mean pressure
gradient across studied prosthetic valve.
RESULTS Stuck valve was managed with thrombolysis with strepto-
kinase in 16 patients of Rheumatic heart disease who have undergone
Prosthetic mechanical valve implantation. All but one had St Jude
bileaﬂet prosthesis as implant (size 27 – 28mm) . One patient had TTK
chitra valve implanted. Average time of stuck valve after surgery was
14 months. Stuck valve occurred in mitral position in all except one in
aortic position. Low INR at admission indicating suboptimal anti-
coagulation was the major cause of stuck valve which in turn was
mainly due to discontinuation of oral anticoagulant therapy. Acute
pulmonary edema was the most common presentation followed by
worsening class of dyspnea. Thrombolysis with streptokinase was
successful in restoring valve movements with fall in mean gradient in
94% of cases. Redo thrombolysis in successfully thrombolyzed patient
for stuck valve previously with same agent failed probably due to
development of antibodies. 2 patients developed stroke in the process
of thrombolysis which is of embolic origin and CT scan revealed no
hemorrhage. Minor bleeding was noted in 32% of cases in form of gum
bleeding and hematuria. No signiﬁcant allergic reactions encountered.
Overall thrombolysis was successful in majority of the cases with no
major life threatening complications. Thus streptokinase as a throm-
bolytic agent is deﬁnitely a low cost, safe and effective treatment
alternative for high risk redo surgical procedure in patients of stuck
valve in rheumatic heart disease.
CONCLUSION Stuck valve is the major complication in long run in a
patient of valvular heart disease who has undergone mechanical
prosthetic valve implantation. Early recognition and successful
thrombolysis is a safe and effective alternative to a more cumbersome
high risk redo valve surgery for such cases. Streptokinase is safe, cost-
effective thrombolytic agent for naive cases presenting with stuck
valve.
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BACKGROUND Rheumatic fever and rheumatic heart disease
continue to be the major health problem in all developing countries
including Bangladesh. Rheumatic mitral stenosis is a very common
problem in our population having an incidence of 54 percent among
rheumatic heart disease with a female preponderance of 2:1. Percu-
taneous balloon mitral commissurotomy is appealing because the
mechanism of valve dilation closely parallels the mechanism of sur-
gical mitral commissurotomy. The technique of balloon mitral com-
missurotomy has evolved rapidly, with improvements in balloons,
guide wires, and the application of double-balloon techniques.
Percutaneous transvenous mitral commissurotomy (PTMC) using an
Inoue balloon catheter is of established efﬁcacy and safety and is an
alternative to surgical valvotomy in selected patients with rheumatic
mitral stenosis. Mitral valve Wilkins echo score have shown to be an
important factor in determining immediate outcome of patients un-
dergoing surgical mitral commissurotomy. Patient selection has an
important impact on the outcome of percutaneous balloon mitral
commissurotomy.
METHODS A prospective study was done in National Institute of Car-
diovascular Diseases, Dhaka, Bangladesh and Al- Helal Heart Institute,
Mirpur, Dhaka during the period of August 2003 to June 2014. Nine
hundred and ninety (990) patients with rheumatic mitral stenosis who
underwent PTMC were evaluated clinically, by echocardiography and
by catheter during and after procedure. Out of 990 patients 60 patients
hadWilkins Echo score>8 (9-12) (Group-1) and rest 930 patients had low
and medium Wilkins Echo score < 8 (Group-2).RESULTS Mean age of the study population was 33.36  09.80 years
in group-1 and 23.14  11.21years in Group-2. Most of the population
are female, 70%in Group-1 and 78% ingroup-2.After PTMC mean
mitral valve area increased from 0.80  0.11 cm2to1.46  0.27 cm2 as
measured by echocardiography in group-1 and from 0.85  0.32 cm2 to
1.81  0.33 cm2in group-2. Mitral valve gradient reduced to 11.63 
4.15 mm Hg from 32.46  03.94 mm Hg after PTMC in group-1 and
10.45 3.76 mm Hg from 26.64  04.12 mm Hg after PTMC in group-2.
Mean left atrial pressure as recorded by catheter before PTMC was
33.99  08.37 mmHg while after PTMC it was 21.81  06.28mm Hg in
group-1 and 28.81  07.32 mm Hg while after PTMC it was 17.76 
05.11 mm Hg in group-2. High Wilkins Echo score group (Group-1) had
higher NYHA class, higher atrial ﬁbrillation and higher commissural
calcium score.
CONCLUSION Though PTMC is an effective procedure for patients
with high Wilkins score but result is inferior to patients with low and
medium echo score.TCTAP A-182
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BACKGROUND Rheumatic fever and rheumatic heart disease
continue to be the major health problem in all developing countries
including Bangladesh. Rheumatic mitral stenosis is a very common
problem in our population having an incidence of 54 percent among
rheumatic heart disease with a female preponderance of 2:1. Percu-
taneous balloon mitral commissurotomy is appealing because the
mechanism of valve dilation closely parallels the mechanism of sur-
gical mitral commissurotomy. The technique of balloon mitral com-
missurotomy has evolved rapidly, with improvements in balloons,
guide wires, and the application of double-balloon techniques. So, we
aimed to assess the immediate in-hospital complications of percuta-
neous transvenous mitral commissurotomy (PTMC) in patients with
symptomatic moderate to severe rheumatic mitral stenosis in our
population.
METHODS A prospective study was done in National Institute of
Cardiovascular Diseases, Dhaka, Bangladesh and Al- Helal Heart
Institute, Mirpur, Dhaka during the period of August 2003 to June
2014. Nine hundred and ninety (990) patients with rheumatic mitral
stenosis who underwent PTMC were evaluated clinically, by echo-
cardiography and by catheter during and after procedure.
RESULTS Mean age of the study population was 28.31  11.21 years.
Most of the populations are female (81%). After PTMC mean mitral
valve area increased from 0.83  0.11cm2 to 1.76  0.27 cm2 as
measured by echocardiography. Mitral valve gradient reduced to
11.63  4.15 mm Hg from 28.46  03.94 mm Hg after PTMC. Left atrial
size also decreased from 48.27  07.76 mm to 37.25  08.62 mm.
Mean left atrial pressure as recorded by catheter before PTMC was
30.99  08.37 mm Hg while after PTMC it was 13.81 06.28 mm Hg.
Mean aortic pressure increased from 91  04 mm Hg to 98  07 mm
Hg after the procedure. There was no procedural death. There were
4 patients in- hospital death. 2 patients died from massive CVD
after PTMC. 1 patient died from renal failure and electrolyte imbal-
ance, 1 patient died from multi system organ failure due to sepsis
unrelated to PTMC. There were 2þmitral regurgitation in 3 patients or
3þ post PTMC mitral regurgitation in 1 patient as assessed by left
ventriculography. There was no TCTAP A-V block during or after
PTMC.
Pericardial tamponade occurred in 5 patients post procedure and
those patients were successfully treated with pericardiocentesis in the
catheterization laboratory under echo guidance and PTMC was
completed successfully. Thromboembolic events occurred in 04 pa-
tients and in 2 patients massive CVD and in 2 patients TIA. Left to right
shunt (ASD) occurred in 30 patients. Local vascular complications like
pain, hemorrhage, hematoma occurred in 69 patients.
CONCLUSION PTMC is a very effective and safe procedure at relieving
the hemodynamic effects of rheumatic mitral stenosis. It is an alter-
native to closed mitral commissurotomy (CMC) and intervention of
choice of symptomatic rheumatic mitral stenosis with suitable mitral
valve morphology. Complications during the procedure were very few.
